The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EORTC CLTF 2021 | The cancer immune contexture
Jérôme Galon, MD, PhD, Inserm, Paris, France, gives an overview of the cancer immune contexture, defined as the immune parameters associated with patient survival, including the types of immune cells infiltrating tumors, the quantity of these cells, the location of immune cells, and the quality of the immune response. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.
